Antiviral completion rates and sustained viral response in hepatitis C patients with and without preexisting major depressive disorder
- PMID: 19855036
- PMCID: PMC2987665
- DOI: 10.1176/appi.psy.50.5.500
Antiviral completion rates and sustained viral response in hepatitis C patients with and without preexisting major depressive disorder
Abstract
Background: Despite evidence suggesting that the majority of patients with hepatitis C virus (HCV) have psychiatric and substance use disorders, patients with these comorbidities have historically been excluded from antiviral therapy for HCV.
Objective: The authors compared antiviral completion and sustained virologic response (SVR) rates between hepatitis C (HCV) patients with versus those without preexisting major depressive disorder (MDD).
Method: The authors performed a chart review of HCV patients (30 with MDD and 25 control subjects) who attended an optional HCV education class and signed informed consent allowing collection of clinical data.
Results: The MDD group had completion and SVR rates similar to those of control subjects. Neuropsychiatric side effects and reasons for discontinuation of treatment were not different between groups.
Conclusion: Patients with MDD can be safely and effectively treated with antiviral therapy.
References
-
- Cheung RC. Epidemiology of hepatitis C virus infection in American veterans. Am J Gastroenterol. 2000;95:740–747. - PubMed
-
- El-Serag HB, Kunik M, Richardson P, et al. Psychiatric disorders among veterans with hepatitis C infection. Gastroenterology. 2002;123:476–482. - PubMed
-
- Fireman M, Indest DW, Blackwell Scientific A, et al. Addressing tri-morbidity (hepatitis C, psychiatric disorders, and substance use): the importance of routine mental health screening and a component of a co-management model of care. Clin Infect Dis. 2005;(suppl 5):S286–S291. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
